PTM Therapeutics, Inc.
Edit

PTM Therapeutics, Inc.

https://www.ptmthera.com/
Last activity: 18.11.2020
PTM Therapeutics is focused on developing antibody therapeutics targeting post-translational modifications including glycans. Its primary asset, PTM-001 is being developed for the treatment of Inflammatory Bowel Disease (IBD). Unlike existing IBD therapies PTM-001 does not directly target the immune system but instead, promotes intestinal mucosal wound healing and has demonstrated promising efficacy in in vivo IBD models.
Website visits
6.9K /mo.
Location: United States, California, San Mateo
Employees: 1-10
Founded date: 2019

Investors 3

Reviews 0

Sign up to leave a review

Sign up Log In